Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

47,962 studies found

Not Yet Recruiting
Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(...

Conditions: Multiple Myeloma (MM)

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic...

Conditions: Severe Hemophilia A

Institute of Hematology & Blood Diseases Hospital Chine...

View details
Recruiting
CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Active Not Recruiting
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-...

Conditions: B-cell Non-Hodgkin Lymphoma

Institute of Hematology and Blood Diseases Hospital ,Ch...

View details
Active Not Recruiting
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary P...

Conditions: Plasma Cell Leukemia

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Conditions: Relapsed and Refractory CD5 Hematological Tumors

Hematology Hospital of Chinese Academy of Medical Scien...

View details
Recruiting
A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treatin...

Conditions: Adult Non-infectious Uveitis

Tianjin Medical University Eye Hospital Tianjin Tianjin...

View details
Recruiting
Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carc...

Conditions: Renal Cell Carcinoma (Kidney Cancer)

Tianjin Medical University Second Hospital Tianjin Tian...

View details
Active Not Recruiting
Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI

Conditions: HCC - Hepatocellular Carcinoma

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Rena...

Conditions: Renal Cell Carcinoma (RCC)

Changyi Quan Tianjin Tianjin Municipality

View details
Active Not Recruiting
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.

Conditions: Biliary Tract Cancers (BTC)

Tianjin Medical University Cancer Institute and Hospita...

View details
Not Yet Recruiting
Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointest...

Conditions: Postoperative Pain, Postoperative Ileus

Tianjin First Central Hospital Tianjin Tianjin Municipa...

View details
Recruiting
An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therap...

Conditions: Digestive System Malignancies

Patients with esophageal, pancreatic, gastric, or color...

View details
Active Not Recruiting
Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepa...

Conditions: Intrahepatic Cholangiocarcinoma (Icc)

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Can...

Conditions: Breast Cancer

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment

Conditions: Amnestic Mild Cognitive Impairment - aMCI, AD-MCI, AD - Alzheimer's Disease, FTD

Tianjin Huanhu Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients

Conditions: HER2positive, Advanced Breast Cancer, HER2 + Breast Cancer

Tianjin Medical University Cancer Insititute and Hospit...

View details
Recruiting
Phase I Study of HRS-3005 in B-cell Malignancies

Conditions: B-cell Malignancy

Hematology Hospital of the Chinese Academy of Medical S...

View details
Recruiting
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma

Conditions: Relapsed or Refractory Multiple Myeloma

Institute of Hematology & Blood Diseases Hospital Tianj...

View details
Active Not Recruiting
A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53...

Conditions: Multiple Myeloma

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Not Yet Recruiting
LILRB4 STAR-T Cell Therapy for Monocytic Leukemia

Conditions: Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia

China

View details
Recruiting
MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours

Conditions: Endovascular Thrombectomy

China

View details
Recruiting
CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblasti...

Conditions: Acute Lymphocytic Leukemia

China

View details
Recruiting
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cel...

Conditions: Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation

China

View details